Marco M. Kessler - Concepedia

Concepedia

Author

Marco M. Kessler

Ironwood Pharmaceuticals (United States)

Also Known As

M Kessler, M M Kessler, M. KESSLER, M.M. Kessler, Marco Kessler, Marco M Kessler, Marco M. Kessler

40

Publications

1.8K

Citations

20

H-Index

57

Concepts

All Affiliations

Ironwood Pharmaceuticals (United States)Tufts University Texas A&M University NKT Therapeutics (United States)DecImmune Therapeutics (United States)

MM

About

Marco M. Kessler is an author at Ironwood Pharmaceuticals (United States) specializing in medicine, natural sciences, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	555
2	Natural Sciences	5	5	317
3	Biochemistry	3	3	477
4	Engineering	1	1	27
5	Biology	1	1	17

Marco M. Kessler

×

25

Publications

1.8K

Citations

20

H-Index

	Year	Citations
Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit Robert Busby, Alexander P. Bryant, Wilmin Bartolini, European Journal of Pharmacology Signal TransductionBiochemistryEnhanced Intestinal SecretionNatural SciencesGastroenterology	2010	245
Hrp1, a sequence-specific RNA-binding protein that shuttles between the nucleus and the cytoplasm, is required for mRNA 3′-end formation in yeast Marco M. Kessler, Michael F. Henry, Elisa C. Shen, Genes & Development	1997	229
Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract Alexander P. Bryant, Robert Busby, Wilmin Bartolini, Life Sciences Molecular PharmacologyBiochemistryGastrointestinal PharmacologyMedicineGastroenterology	2010	221
INHIBITION OF FERTILIZATION <i>IN VIVO</i> BY PANCREATIC AND SEMINAL PLASMA TRYPSIN INHIBITORS Lourens J.D. Zaneveld, Richard T. Robertson, Marco M. Kessler, Reproduction	1971	140
Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation Robert Busby, Marco M. Kessler, Wilmin Bartolini, Journal of Pharmacology and Experimental Therapeutics	2012	132
Purification of the Saccharomyces cerevisiae Cleavage/Polyadenylation Factor I Marco M. Kessler, Jing Zhao, Claire Moore Journal of Biological Chemistry	1996	87
Pta1, a Component of Yeast CF II, Is Required for Both Cleavage and Poly(A) Addition of mRNA Precursor Jing Zhao, Marco M. Kessler, Steffen Helmling, Molecular and Cellular Biology	1999	85
Identification of potential cell‐surface proteins in <i>Candida albicans</i> and investigation of the role of a putative cell‐surface glycosidase in adhesion and virulence Christine Alberti‐Segui, Arturo J. Morales, Heming Xing, Yeast	2004	77
Bibliographic coupling extended in time: Ten case histories Marco M. Kessler Information Storage and Retrieval BibliometricsCitation AnalysisCase HistoriesCommunicationCitation Graph	1963	73
Gastrointestinal pain: Unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation Inmaculada Silos‐Santiago, Gerhard Hannig, Hélène Eutamène, Pain	2013	69

Page 1